1 results match your criteria: "Sun Yat-Sen University and Zhongshan People's Hospital[Affiliation]"
Meta-analysis of inoperable pancreatic cancer: gemcitabine combined with cisplatin versus gemcitabine alone.
Chin J Dig Dis
July 2006
Department of Oncology, The Second Affiliated Hospital, Sun Yat-Sen University and Zhongshan People's Hospital, Zhongshan, Guangdong Province, China.
Objectives: To compare the therapeutic effects of gemcitabine (GEM) monotherapy with GEM-cisplatin (DDP) combination chemotherapy in patients with advanced stage pancreatic cancer (APCa) through meta-analysis.
Methods: MEDLINE and EMBASE searches were supplemented by information from trial registers of randomized controlled trials (RCTs) for GEM-DDP combination chemotherapy and GEM alone in APCa. A quantitative meta-analysis using updated information based on inclusion criteria from all available RCTs was carried out by two reviewers.